Share class: United Therapeutics Corporation

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A174,567,36343,665,794 ( 58.56 %) 30,076,187 ( 40.33 %) 58.56 %

Major shareholders: United Therapeutics Corporation

NameEquities%Valuation
BlackRock Advisors LLC
11.10 %
4,937,868 11.10 % 1 795 M $
Vanguard Fiduciary Trust Co.
9.932 %
4,418,963 9.932 % 1 607 M $
Wellington Trust Co., NA
7.384 %
3,285,289 7.384 % 1 194 M $
Avoro Capital Advisor LLC
6.426 %
2,858,888 6.426 % 1 039 M $
State Street Corp.
5.157 %
2,294,233 5.157 % 834 M $
Renaissance Technologies LLC
4.888 %
2,174,692 4.888 % 791 M $
Citigroup Global Markets, Inc. (Broker)
3.654 %
1,625,605 3.654 % 591 M $
Geode Capital Management LLC
2.357 %
1,048,449 2.357 % 381 M $
LSV Asset Management
2.172 %
966,370 2.172 % 351 M $
Morgan Stanley Investment Management, Inc.
1.814 %
806,988 1.814 % 293 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░

Breakdown by shareholder type

Institutional84.42%
Other12.85%
State Street Corp.5.16%
Individuals1.75%
Swedbank AB0.95%
Schweizerische Nationalbank0.30%
Sumitomo Mitsui Trust Holdings, Inc.0.22%
Manulife Financial Corp.0.22%
Skandinaviska Enskilda Banken AB0.20%
Governments0.17%
SEI Investments Co.0.14%
Corebridge Financial, Inc.0.13%
First Financial Bankshares, Inc.0.03%
MidWestOne Financial Group, Inc.0.02%
Hancock Whitney Corp.0.01%
Rathbones Group Plc0.01%
Cadence Bank0.01%
The Bank of Nova Scotia0.01%

Based on 1000 largest holdings

Geographical origin of shareholders

United States 88.28%
United Kingdom 4.34%
Canada 2.20%
Individuals 1.75%
Sweden 1.69%
France 1.49%
Australia 1.45%
Denmark 0.99%
Netherlands 0.66%
Switzerland 0.65%
Norway 0.57%
Japan 0.48%
Belgium 0.39%
Luxembourg 0.37%
Ireland 0.30%
Germany 0.28%
South Korea 0.23%
Cayman Islands 0.17%
Finland 0.09%
Austria 0.06%
Italy 0.04%
Singapore 0.04%
China 0.03%
Estonia 0.02%
Mexico 0.01%
Liechtenstein 0.01%

Based on 1000 largest holdings

Logo United Therapeutics Corporation
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
Employees
1,168
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW